{"nct_id":"NCT05029882","title":"Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2021-10-13","start_date_type":"ACTUAL","primary_completion_date":"2027-11","primary_completion_date_type":"ESTIMATED","completion_date":"2027-11","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ABBV"]}